| Considerable
research effort is now devoted to the development of vaccines to
prevent infection by oncogenic infectious agents, as well as to
mount an immune response against cancer-specific epitopes) and
to potential venues for gene therapy for individuals with
genetic mutations or polymorphisms that put them at high risk of
cancer.
As reported above, a preventive human papillomavirus vaccine
exists that targets certain sexually transmitted strains of
human papillomavirus that are associated with the development of
cervical cancer and genital warts. The only two HPV vaccines on
the market as of October 2007 are Gardasil and Cervarix
Prevention Screening >>
|
Cancer
Classification
1. Nomenclature
2. Adult cancers
3. Childhood cancers
Signs and symptoms
Diagnosis
1. Investigation
2. Biopsy
Treatment
1. Surgery
2. Radiation therapy
3. Chemotherapy
4. Targeted therapies
5. Immunotherapy
6. Hormonal therapy
7. Symptom control
8. Complementary and alternative
9. Treatment trials
Prognosis
1. Emotional impact
Causes
1. Chemical carcinogens
2. Ionizing radiation &
Infectious diseases
3. Hormonal imbalances
& Immune system dysfunction
4. Heredity & Other causes
Pathophysiology
1. Epigenetics
2. Oncogenes
3. Tumor suppressor genes
4. Cancer cell biology
4.1 Clonal evolution
4.2 Biological properties of cancer cells
Prevention
1. Modifiable ("lifestyle") risk factors
2. Diet
3. Vitamins
4. Chemoprevention
5. Genetic testing
6. Vaccination
7. Screening
Epidemiology
History
Research |